The anti-cancer effects of lipid-soluble vitamins in various GBM cell lines are attributed to a diverse range of molecular mechanisms through changes in the expression of a wide range of biomarkers, of which CDK2, GFAP, p27, Bax, and CASP8 genes may have some clinical value. The gene discussed is CDK2; the disease is cancer.